THERE is limited experience in patients 2 years of age and older or with body weight above 13.5 kg. The safety and efficacy of onasemnogene abeparvovec in these patients have not been established. Disponível em: https://
THERE is limited experience in patients 2 years of age and older or with body weight above 13.5 kg. The safety and efficacy of onasemnogene abeparvovec in these patients have not been established. Disponível em: https://
Tempo estimado para leitura:3 min
Você não tem permissão para visualizar este conteúdo.
